Home/Pipeline/IMX113

IMX113

Rare Pediatric Disease

PreclinicalActive

Key Facts

Indication
Rare Pediatric Disease
Phase
Preclinical
Status
Active
Company

About Imunexus Therapeutics

Australian biotech that 'turbo‑charges' existing biologics into multispecific therapeutics for oncology and neuro‑immune diseases.

View full company profile